180 related articles for article (PubMed ID: 36194908)
1. Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis.
Volpe S; Piperno G; Colombo F; Biffi A; Comi S; Mastroleo F; Maria Camarda A; Casbarra A; Cattani F; Corrao G; de Marinis F; Spaggiari L; Guckenberger M; Orecchia R; Alterio D; Jereczek-Fossa BA
Cancer Treat Rev; 2022 Nov; 110():102464. PubMed ID: 36194908
[TBL] [Abstract][Full Text] [Related]
2. Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer.
Gomez DR; Gillin M; Liao Z; Wei C; Lin SH; Swanick C; Alvarado T; Komaki R; Cox JD; Chang JY
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):665-70. PubMed ID: 23688815
[TBL] [Abstract][Full Text] [Related]
3. Dose escalation study of proton beam therapy with concurrent chemotherapy for stage III non-small cell lung cancer.
Harada H; Fuji H; Ono A; Kenmotsu H; Naito T; Yamashita H; Asakura H; Nishimura T; Takahashi T; Murayama S
Cancer Sci; 2016 Jul; 107(7):1018-21. PubMed ID: 27110950
[TBL] [Abstract][Full Text] [Related]
4. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated proton beam therapy for centrally located lung cancer.
Nakamura N; Hotta K; Zenda S; Baba H; Kito S; Akita T; Motegi A; Hojo H; Nakamura M; Parshuram RV; Okumura M; Akimoto T
J Med Imaging Radiat Oncol; 2019 Aug; 63(4):552-556. PubMed ID: 31145553
[TBL] [Abstract][Full Text] [Related]
6. High-dose proton beam therapy for stage I non-small cell lung cancer: Clinical outcomes and prognostic factors.
Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Azami Y; Kato T; Tsukiyama I; Hareyama M; Kikuchi Y; Daimon T; Hata M; Inoue T; Fuwa N
Acta Oncol; 2015 Mar; 54(3):307-14. PubMed ID: 25291076
[TBL] [Abstract][Full Text] [Related]
7. High-dose hypofractionated proton beam radiation therapy is safe and effective for central and peripheral early-stage non-small cell lung cancer: results of a 12-year experience at Loma Linda University Medical Center.
Bush DA; Cheek G; Zaheer S; Wallen J; Mirshahidi H; Katerelos A; Grove R; Slater JD
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):964-8. PubMed ID: 23845845
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of dynamic adaptive passive scattering proton therapy with computed tomography image guidance in the lung.
Moriya S; Tachibana H; Hotta K; Nakamura N; Sakae T; Akimoto T
Med Phys; 2017 Sep; 44(9):4474-4481. PubMed ID: 28665491
[TBL] [Abstract][Full Text] [Related]
9. Clinical results of proton beam therapy for elderly patients with non-small cell lung cancer.
Ono T; Nakamura T; Yamaguchi H; Azami Y; Takayama K; Suzuki M; Wada H; Kikuchi Y; Murakami M; Nemoto K
Radiat Oncol; 2018 Feb; 13(1):19. PubMed ID: 29402290
[TBL] [Abstract][Full Text] [Related]
10. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
11. Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.
Liao Z; Lee JJ; Komaki R; Gomez DR; O'Reilly MS; Fossella FV; Blumenschein GR; Heymach JV; Vaporciyan AA; Swisher SG; Allen PK; Choi NC; DeLaney TF; Hahn SM; Cox JD; Lu CS; Mohan R
J Clin Oncol; 2018 Jun; 36(18):1813-1822. PubMed ID: 29293386
[TBL] [Abstract][Full Text] [Related]
12. High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study.
Liu YE; Lin Q; Meng FJ; Chen XJ; Ren XC; Cao B; Wang N; Zong J; Peng Y; Ku YJ; Chen Y
Radiat Oncol; 2013 Aug; 8(1):198. PubMed ID: 23937855
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated Versus Standard Fractionated Proton-beam Therapy for Low-risk Prostate Cancer: Interim Results of a Randomized Trial PCG GU 002.
Vargas CE; Hartsell WF; Dunn M; Keole SR; Doh L; Eisenbeisz E; Larson GL
Am J Clin Oncol; 2018 Feb; 41(2):115-120. PubMed ID: 26523442
[TBL] [Abstract][Full Text] [Related]
14. Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 Trial.
Hoppe BS; Nichols RC; Flampouri S; Pankuch M; Morris CG; Pham DC; Mohindra P; Hartsell WF; Mohammed N; Chon BH; Kestin LL; Simone CB
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(4):732-741. PubMed ID: 35306151
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Clinical Safety of High-Dose Proton Radiation Therapy Delivered With Pencil Beam Scanning Technique for Extracranial Chordomas and Chondrosarcomas in Adult Patients: Clinical Evidence of Spinal Cord Tolerance.
Stieb S; Snider JW; Placidi L; Kliebsch U; Lomax AJ; Schneider RA; Weber DC
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):218-225. PubMed ID: 29029887
[TBL] [Abstract][Full Text] [Related]
16. Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas : Ablative dose PBT for NSCLC.
Lee SU; Moon SH; Cho KH; Pyo HR; Kim JY; Kim DY; Kim TH; Suh YG; Kim YJ
Strahlenther Onkol; 2016 Sep; 192(9):649-57. PubMed ID: 27282279
[TBL] [Abstract][Full Text] [Related]
17. Tumor Control Probability Analysis for Single-Fraction Carbon-Ion Radiation Therapy of Early-Stage Non-small Cell Lung Cancer.
Paz AE; Yamamoto N; Sakama M; Matsufuji N; Kanai T
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1551-1559. PubMed ID: 30076985
[TBL] [Abstract][Full Text] [Related]
18. Variation of the relative biological effectiveness with fractionation in proton therapy: Analysis of prostate cancer response.
Pardo-Montero J; Pombar M; Gómez-Caamaño A; Giordanengo S; González-Crespo I
Med Phys; 2023 Nov; 50(11):7304-7312. PubMed ID: 37818904
[TBL] [Abstract][Full Text] [Related]
19. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.
Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Ishikawa Y; Azami Y; Kato T; Tsukiyama I; Kikuchi Y; Hareyama M; Murakami M; Fuwa N; Hata M; Inoue T
Radiat Oncol; 2014 Jan; 9():26. PubMed ID: 24422711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
